MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with S

Selegiline

Selegiline 5mg tablets

Use with caution

Stability notes for Selegiline 5mg tablets

Store in an airtight container and protect from light.

Provenance

This compatibility recommendation is derived from Eldepryl 5mg tablets (Orion Pharma (UK) Ltd).

Supplier

Eldepryl 5mg tablets (Orion Pharma (UK) Ltd)

Selegiline 10mg tablets

Use with caution

Stability notes for Selegiline 10mg tablets

Store in an airtight container and protect from light.

Provenance

This compatibility recommendation is derived from Eldepryl 10mg tablets (Orion Pharma (UK) Ltd).

Supplier

Eldepryl 10mg tablets (Orion Pharma (UK) Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.